Indiva because of edibles licensed by established successful brands with Canadian exclusivities, and Aleafia because of cultivation growth coupled with their own chain of clinics and Cannabis 2.0 growing SKUs growth.
Aleafia’s Q4 growth should be explosive in comparison to prior years and Qs. That’s the bet. Plenty of debt and other Red Flags so be cautious. I have been buying more.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.